ConductScience.org, home
VSIR: V-set immunoregulatory receptor
API referenceFor AI assistants

Gene · 64115

Papers2,513

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

41 to 60 of 2,513

Download this page as JSON
TitleJournalYearPMIDFound bySource
Targeting of VISTA with Cyclic Peptide-Based PET Tracers for Immune Checkpoint Imaging.Mol Pharm202641978961PubTator, text miningPubMed
Galectin-9 in cancer: Unraveling its diverse roles beyond immune regulation.Biochim Biophys Acta Rev Cancer202641956335PubTator, text miningPubMed
Molecular profiling of sacral chordomas through methylation, spatial transcriptomics and multiplexed immunofluorescence.ESMO Rare Cancers202641924303PubTator, text miningPubMed
The 15-year bibliometric landscape of glioblastoma vaccines: Emergence of combinatorial immunotherapy.Hum Vaccin Immunother202641919662PubTator, text miningPubMed
Role of Bioinformatics in Identifying Novel Biomarkers for Immune Cell Exhaustion and Tumor Microenvironment.Technol Cancer Res Treat202641919636PubTator, text miningPubMed
Emerging immune checkpoint targets and combination strategies in blood cancer immunotherapy.Ann Hematol202641915070PubTator, text miningPubMed
Regulated transformation system (RTS): sddi-mediated programmable shut-off and mode switching of base editors.Nucleic Acids Res202641909950PubTator, text miningPubMed
Advances in Spatial Multi-Omics in Gastric Cancer.Cells202641892326PubTator, text miningPubMed
Nuclear prostaglandin E synthase 3 promotes hepatocellular carcinoma growth with immunosuppressive macrophage polarization via the SP1/TGF-β axis.Mol Biomed202641880053PubTator, text miningPubMed
VISTA promotes ovarian cancer progression through activation of NF-κB pathway and tumor microenvironment reprogramming.J Ovarian Res202641857615PubTator, text miningPubMed
Research progress on the molecular mechanisms of PD-1 and LAG-3 synergy in regulating T cell exhaustion and immunotherapy.Ann Med202641846252PubTator, text miningPubMed
Immune checkpoint molecules beyond PD-1 and CTLA-4: emerging targets in autoimmune diseases and cancer immunotherapy.Inflamm Res202641842954PubTator, text miningPubMed
Balancing the Dual Mechanisms of Anti-VISTA mAbs for Antitumor Activity: CD8+ T-cell Responses and Fc-Dependent Depletion of VISTA-Expressing Immune Cells.Mol Cancer Ther202641841398PubTator, text miningPubMed
T cell-intrinsic VISTA expression promotes resistance to CTLA-4 blockade by restricting CD8+ T cell responses.J Clin Invest202641837284PubTator, text miningPubMed
Next-Generation Immune Checkpoints and Tumor Microenvironment Modulation in Cancer Immunotherapy.J Immunol Res202641811823PubTator, text miningPubMed
Differences in the expression profiles of m6A-related genes and the prognostic role in immunotherapy for lung adenocarcinoma patients.Front Oncol202641809822PubTator, text miningPubMed
Drug Delivery Systems for Resiquimod to Control Myeloid-Derived Suppressor Cells in Cancer Immunotherapy.Wiley Interdiscip Rev Nanomed Nanobiotechnol202641804092PubTator, text miningPubMed
Tumor Cells as Architects of Immune Refractoriness: Dismantling Intrinsic Programs of Tumor Cells for Clinical Translation.Immune Netw202641800027PubTator, text miningPubMed
Research on the Mechanism of "Cold Tumor" Formation and Immunotherapy for Its Transformation into "Hot Tumor".Oncol Res202641799503PubTator, text miningPubMed
Pro-tumourigenic effects of DCAF13 on the progression of colorectal cancer.Oncol Lett202641797888PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Previous pageNext page

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/64115/papers?page=3

API referenceFor AI assistants